Cutaneous verrucous tuberculosis

Authors

  • Vanina Elisabet Cuestas Dr. Abel Zubizarreta Hospital, City of Buenos Aires, Argentina
  • Graciela Sánchez Dr. Abel Zubizarreta Hospital, City of Buenos Aires, Argentina
  • Gladys Manuela Sánchez Dr. Abel Zubizarreta Hospital, City of Buenos Aires, Argentina
  • Karina Cejas Dr. Abel Zubizarreta Hospital, City of Buenos Aires, Argentina
  • Diego Silva Dr. Abel Zubizarreta Hospital, City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/da.v30i3.2682

Keywords:

cutaneous verrucous tuberculosis, Mycobacterium tuberculosis

Abstract

Cutaneous tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. The verrucous cutaneous variety presents itself as a localized dermatosis, which can result from endogenous reinfection or external inoculation. We present the case of a 32-year-old male patient who exhibited an asymptomatic plaque erythematous-violaceous, indurated, and had a verrucous surface on the right wrist, with a duration of 7 months. Complementary tests, including a negative PPD (purified protein derivative) and positive culture for Mycobacterium tuberculosis, were conducted. Antifimic treatment was prescribed, with good response.

Author Biographies

  • Vanina Elisabet Cuestas, Dr. Abel Zubizarreta Hospital, City of Buenos Aires, Argentina

    Physician

  • Graciela Sánchez, Dr. Abel Zubizarreta Hospital, City of Buenos Aires, Argentina

    Head of the Pathological Anatomy Service

  • Gladys Manuela Sánchez, Dr. Abel Zubizarreta Hospital, City of Buenos Aires, Argentina

    Dermatologist

  • Karina Cejas, Dr. Abel Zubizarreta Hospital, City of Buenos Aires, Argentina

    Plant Doctor

  • Diego Silva, Dr. Abel Zubizarreta Hospital, City of Buenos Aires, Argentina

    Head of Dermatology Service

References

I. Sánchez-Cárdenas CD, Palomares MP, Arenas-Guzmán R. Tuberculosis verrucosa cutis. Med Int Méx. 2018;34:349-353.

II. Gómez-Sierra MS, Bolomo G, Bañez MJ, Miraglia E, et ál. Tuberculosis cutánea: lupus vulgar. Arch Argent Dermatol. 2016;66:82-85.

III. Belo dos Santos J, Figueiredo AR, Ferraz CE, De Oliveira MH, et ál. Cutaneous tuberculosis: epidemiologic, etiopathogenic and clinical aspects, Part I. An Bras Dermatol. 2014;89:219-229.

IV. Velayati AA, Farnia P. The species concept. En: Atlas of Myobacteriumtuberculosis, Elsevier, San Diego, Ca, 2017, pp. 1-16.

V. Pizzariello G, Fernández-Pardal P, D´Atri G, Novac V, et ál. Espectro clínico de tuberculosis cutánea. Rev Argent Dermatol. 2008;89(3).

VI. Reyes-Weaver DA, Parral-Pacheco JM, Huitzil-Palafox SY, Lavariega-Aquino A, et ál. Tuberculosis cutánea verrugosa: informe de un caso en una localización atípica. Dermatología CMQ 2022;20:427-430

VII. Prasanna S, Mithari H, Kharkar V. A cross sectional descriptive study of dermoscopic features of clinical variants of cutaneous tuberculosis. Indian J Tuberc. 2023;70:501-507.

VIII. Gündüz Ö, Koçak G, Kaçmaz B, Devrim T, et ál. Intralesional avirulent Bacillus Calmette-Guérin injection as a promising method for the treatment of Tuberculosis Verrucosa Cutis. Case Rep Dermatol. 2022;14:49-54.

Downloads

Published

2024-10-21

Issue

Section

Clinical Cases